Contineum Therapeutics (CTNM) Shares Outstanding (Diluted) (2023 - 2026)
Contineum Therapeutics' Weighted Average Shares Outstanding (Diluted) was 38.39 million in Q3 2026, up 36.5% from 28.12 million a year earlier and up 2.5% from the prior quarter.
Contineum Therapeutics (CTNM) Shares Outstanding (Diluted) (2023 - 2026) Analysis & Trends
For FY2025, Weighted Average Shares Outstanding (Diluted) at Contineum Therapeutics came in at 27.7 million, up 43.1% from FY2024.
- In earlier years, Weighted Average Shares Outstanding (Diluted) was 19.35 million in FY2024 (+470.0%) and 3.4 million in FY2023.
- The Q3 2026 figure marks the highest quarterly Weighted Average Shares Outstanding (Diluted) in data going back to Q1 2023.
- Compared with a year earlier, Weighted Average Shares Outstanding (Diluted) has increased for 11 straight quarters, with growth averaging 206.3% over the last eight quarters.
- The year-over-year growth in Weighted Average Shares Outstanding (Diluted) has ranged between 4.0% (Q1 2024) and 991.9% (Q1 2025) over the last five years.
- Per Business Quant data, CTNM's Weighted Average Shares Outstanding (Diluted) in the three quarters before Q3 2026 was 37.47 million (Q2 2026), 37.34 million (Q1 2026) and 27.7 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 893.40 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.45 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.48 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 1.96 Bn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 1.56 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 546.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.25 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.75 Bn |
| 10 | Contineum Therapeutics | 405.40 Mn | -584.86 Mn | - | 38.39 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 38.39 Mn |
| Jun 30, 2026 | 37.47 Mn |
| Mar 31, 2026 | 37.34 Mn |
| Dec 31, 2025 | 27.70 Mn |
| Sep 30, 2025 | 28.12 Mn |
| Jun 30, 2025 | 25.90 Mn |
| Mar 31, 2025 | 25.87 Mn |
| Dec 31, 2024 | 19.35 Mn |
| Sep 30, 2024 | 25.73 Mn |
| Jun 30, 2024 | 23.36 Mn |
| Mar 31, 2024 | 2.37 Mn |
| Dec 31, 2023 | 3.40 Mn |
| Sep 30, 2023 | 3.45 Mn |
| Jun 30, 2023 | 3.51 Mn |
| Mar 31, 2023 | 2.28 Mn |
Contineum Therapeutics Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=CTNM&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "CTNM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=CTNM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();